A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models
Open Access
- 3 October 2024
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 130 (6) , 1213-1224
Abstract
Background and Objectives: Few preclinical models of pseudomyxoma peritonei (PMP) have been developed, probably due to the tumor's low incidence and its peculiar characteristics of slow growth. Therefore, there is a need to develop more refined PMP models that better reflect its characteristics. The aim of the study is to develop a culture strategy to generate organoid models derived from PMP patient samples.Methods: We followed a strategy based on combinatorial culture conditions that include the different factors essential for PMP growth and that mimic the microenvironment present in the patients.Results: We cultured PMP samples in the presence of the various factors produced by the niche environment of PMP. We obtained 12 PMP organoid models, each of which grows under specific culture conditions. PMP‐derived organoids show long‐term expansion capacity and reproduce the genetic landscape and histological phenotype of the tumor of origin.Conclusion: The organoids we developed faithfully reproduce the key features of PMP disease and will allow us to understand the biology of PMP. With them, we will be able to identify key regulatory networks that support PMP progression, providing a platform for multilevel preclinical testing, identify novel diagnostic biomarkers, and generate novel targets for patient treatments.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG 27619)
This publication has 30 references indexed in Scilit:
- Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistanceCancer and Metastasis Reviews, 2024
- Immune modulatory effects of oncogenic KRAS in cancerNature Communications, 2020
- Tumor Organoids Fill the NicheCell Stem Cell, 2016
- A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during TumorigenesisCell Stem Cell, 2016
- Patient‐derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironmentCancer Medicine, 2016
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer PatientsCell, 2015
- Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendixHuman Pathology, 2014
- Frequent GNAS mutations in low-grade appendiceal mucinous neoplasmsBritish Journal of Cancer, 2013
- Consensus statement on the loco‐regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)Journal of Surgical Oncology, 2008
- Appendiceal neoplasms and pseudomyxoma peritonei: A population based studyEuropean Journal of Surgical Oncology, 2008